e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Treatment and care of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV
1
predict treatment failure during hospitalisation due to COPD exacerbations
J. W. H. Kocks, S. M. Uil, H. Kerstjens, T. van der Molen, J. W. K. van den Berg (Groningen, Zwolle, Netherlands)
Source:
Annual Congress 2007 - Treatment and care of COPD
Session:
Treatment and care of COPD
Session type:
Oral Presentation
Number:
3165
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. W. H. Kocks, S. M. Uil, H. Kerstjens, T. van der Molen, J. W. K. van den Berg (Groningen, Zwolle, Netherlands). Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV
1
predict treatment failure during hospitalisation due to COPD exacerbations. Eur Respir J 2007; 30: Suppl. 51, 3165
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Changes in COPD symptom control questionnaire (CCQ) scores after seven days of treatment with prednisolone of acute exacerbations in hospitalised patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Change in breathlessness and symptom scores during hospitalisation with exacerbations of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 511s
Year: 2004
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
The effect of exacerbation rate on SGRQ (St Georges respiratory questionnaire) score in earlier and later COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
A Comparison of three severity assessment scores: APACHI II SOFA and CURB 65 for predicting inpatient mortality in patients with acute exacerbation of COPD (AECOPD)
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Clinical COPD questionnaire (CCQ) score and mortality
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Symptoms, but not PEF, change during an exacerbation in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 238s
Year: 2003
Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Detecting exacerbations using the clinical COPD questionnaire
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
Physical status and dependence levels in patients with COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept